Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis
Ziqi Ye,1,* Jie Chen,2,* Yuefeng Rao,1 Wenchao Yang3 1Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; 2Department of Pharmacy, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; 3Department of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-12-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/should-s-1-be-better-than-capecitabine-for-patients-with-advanced-gast-peer-reviewed-article-OTT |